| Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride NS Ranpise, SS Korabu, VN Ghodake Colloids and Surfaces B: Biointerfaces 116, 81-87, 2014 | 95 | 2014 |
| Performance parameters and characterizations of nanocrystals: A brief review MM Chogale, VN Ghodake, VB Patravale Pharmaceutics 8 (3), 26, 2016 | 68 | 2016 |
| Cefoperazone sodium liposomal formulation to mitigate P. aeruginosa biofilm in Cystic fibrosis infection: A QbD approach V Ghodake, J Vishwakarma, SL Vavilala, V Patravale International Journal of Pharmaceutics 587, 119696, 2020 | 25 | 2020 |
| Xyloglucan based mucosal nanovaccine for immunological protection against brucellosis developed by supercritical fluid technology S Vyas, S Dhoble, V Ghodake, V Patravale International Journal of Pharmaceutics: X 2, 100053, 2020 | 18 | 2020 |
| Nanoengineered systems for biopesticides VN Ghodake, SV Naik, KN Bhukhanwala, KV Kande, NJ Bhor, ... Handbook of Nanomaterials for Industrial Applications, 243-259, 2018 | 11 | 2018 |
| Site-specific delivery of inhalable antiangiogenic liposomal dry powder inhaler technology ameliorates experimental pulmonary hypertension S Dhoble, V Ghodake, V Peshattiwar, V Patravale Journal of Drug Delivery Science and Technology 62, 102396, 2021 | 7 | 2021 |
| Safe subunit green vaccines confer robust immunity and protection against mucosal Brucella infection in mice MF Abushahba, AS Dadelahi, EL Lemoine, JA Skyberg, S Vyas, S Dhoble, ... Vaccines 11 (3), 546, 2023 | 4 | 2023 |
| Anti-biofilm potential against P. aeruginosa biofilm in cystic fibrosis infection by systemically developed garlic extract incorporated liposomal formulation V Ghodake, S Dhoble, SL Vavilala, V Patravale Journal of Drug Delivery Science and Technology 82, 104359, 2023 | 3 | 2023 |
| Nanoformulations for the therapy of pulmonary infections S Dhoble, V Ghodake, M Chogale, V Patravale Nanostructures for Antimicrobial Therapy, 457-480, 2017 | 3 | 2017 |
| Design, development, and technical considerations for dry powder inhaler devices S Dhoble, A Kapse, V Ghegade, M Chogale, V Ghodake, V Patravale, ... Drug Discovery Today, 103954, 2024 | 2 | 2024 |
| Safe subunit green vaccines confer robust immunity and protection against mucosal Brucella infection in mice. Vaccines. 2023; 11: 546 MF Abushahba, AS Dadelahi, EL Lemoine, JA Skyberg, S Vyas, S Dhoble, ... | 1 | 2023 |
| Targeted Lipid-Based Nanoparticles for Nucleic Acid Delivery in Cancer Therapy P Upadhaya, S Talkar, V Ghodake, N Kadwadkar, A Pandya, S Pulakkat, ... Micro-and Nanotechnologies-Based Product Development, 95-114, 2021 | | 2021 |
| 7 Targeted Lipid-Based P Upadhaya, S Talkar, V Ghodake, N Kadwadkar, A Pandya, S Pulakkat, ... Micro-and Nanotechnologies-Based Product Development, 95, 2021 | | 2021 |
| Nanosuspensions: Formulation, Characterization, and Applications MM Chogale, AA Date, VN Ghodake, SA Payghan, JI Disouza Nanodispersions for Drug Delivery, 133-196, 2018 | | 2018 |
